OQS
ATRC icon

Occudo Quantitative Strategies’s AtriCure ATRC Stock Holding History

Occudo Quantitative Strategies’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,482
Closed -$206K – 636
2025
Q1 		$206K Buy
+6,482
New +$241K 0.03% 560
2024
Q3 		– Sell
-16,682
Closed -$380K – 701
2024
Q2 		$380K Buy
16,682
+3,742
+29% +$86.4K 0.07% 378
2024
Q1 		$394K Buy
12,940
+2,464
+24% +$82.5K 0.07% 381
2023
Q4 		$374K Buy
+10,476
New +$390K 0.05% 474

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Occudo Quantitative Strategies's ATRC Position: Q2 2025 in Review

Occudo Quantitative Strategies sold out of AtriCure (ATRC) in Q2 2025, closing a stake of 6,482 shares — an estimated $206K sold.

Occudo Quantitative Strategies first reported a position in ATRC in Q4 2023 and held it in 4 quarters. The position peaked at $394K in Q1 2024. 201 funds tracked by Wall St. Rank hold ATRC as of Q2 2025.

  • Occudo Quantitative Strategies reported no remaining AtriCure position as of Q2 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 6,482 AtriCure shares in Q2 2025, an estimated $206K.
  • Occudo Quantitative Strategies first reported a position in AtriCure in Q4 2023 and held it in 4 quarters.
  • Occudo Quantitative Strategies's AtriCure position peaked at $394K in Q1 2024.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q2 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.